Abstract
The follow-up procedures subsequent to the primary treatment of a gynecologic malignancy can be assimilated with a screening test performed on the general population. Here the aim of monitoring is the early diagnosis and subsequent treatment of disease recurrence to improve survival of the individual and the population in question.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Armstrong DK (2002) Relapsed ovarian cancer: challenges and management strategies for chronic disease. Oncologist 7:20–28
Jemal A, Siegel R, Ward E et al (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43–66
NIH consensus conference. Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer (1995). JAMA 8:491–497
Agboola OO, Grunfeld E, Coyle D et al (1997) Costs and benefits of routine follow-up after curative treatment for endometrial cancer. CMAJ 157:879–886
Berchuck A, Anspach C, Evans AC et al (1995) Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma. Gynecol Oncol 59:20–24
Kew FM, Roberts AP, Cruickshank DJ (2005) The role of routine follow-up after gynecological malignancy. Int J Gynecol Cancer 15:413–419
Podczaski E, Kaminski P, Gurski K et al (1993) Detection and patterns of treatment failure in 300 consecutive cases of ‘early’ endometrial cancer after primary surgery. Gynecol Oncol 47:323–327
Salvesen HB, Akslen LA, Iversen T et al (1997) Recurrence of endometrial carcinoma and the value of routine follow up. Br J Obstet Gynaecol 104:1302–1307
Shumsky AG, Stuart GC, Brasher PM et al (1994) An evaluation of routine follow-up of patients treated for endometrial carcinoma. Gynecol Oncol 55:229–233
Tjalma WA, van Dam PA, Makar AP et al (2004) The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients. Int J Gynecol Cancer 14:931–937
Averette HE, Ngoyen HN, Donato DN et al (1993) Radical hysterectomy for invasive cervical cancer. Cancer 71:1422–1437
Duyn A, Van Eijkeren M, Kenter G et al (2002) Recurrent cervical cancer: detection and prognosis. Acta Obstet Gynecol Scand 81:351–355
Sugiyama T, Yakushiji M, Noda K et al (2000) Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancer. Oncology 58:31–37
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag
About this chapter
Cite this chapter
Sartori, E., Carrara, L., Pasinetti, B. (2009). Clinical Approach. In: Grazioli, L., Olivetti, L. (eds) Imaging of Urogenital Diseases. Springer, Milano. https://doi.org/10.1007/978-88-470-1344-5_23
Download citation
DOI: https://doi.org/10.1007/978-88-470-1344-5_23
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1343-8
Online ISBN: 978-88-470-1344-5
eBook Packages: MedicineMedicine (R0)